NYSE:LCI - Lannett Stock Price, Price Target & More

$15.85 -0.75 (-4.52 %)
(As of 04/24/2018 08:54 AM ET)
Previous Close$16.60
Today's Range$15.70 - $16.95
52-Week Range$14.40 - $30.35
Volume907,800 shs
Average Volume699,734 shs
Market Capitalization$628.20 million
P/E Ratio5.54
Dividend YieldN/A
Beta2.5

About Lannett (NYSE:LCI)

Lannett logoLannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; and markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:LCI
CUSIP51601210
Phone215-333-9000

Debt

Debt-to-Equity Ratio1.38%
Current Ratio2.32%
Quick Ratio1.77%

Price-To-Earnings

Trailing P/E Ratio5.54
Forward P/E Ratio5.06
P/E Growth1.06

Sales & Book Value

Annual Sales$633.34 million
Price / Sales0.95
Cash Flow$4.1821 per share
Price / Cash3.79
Book Value$15.07 per share
Price / Book1.05

Profitability

EPS (Most Recent Fiscal Year)$2.86
Net Income$-580,000.00
Net Margins7.44%
Return on Equity18.85%
Return on Assets6.62%

Miscellaneous

Employees1,126
Outstanding Shares37,840,000

How to Become a New Pot Stock Millionaire

Lannett (NYSE:LCI) Frequently Asked Questions

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett's earnings last quarter?

Lannett Co Inc (NYSE:LCI) posted its earnings results on Wednesday, February, 7th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.20. The company had revenue of $184.31 million for the quarter, compared to analysts' expectations of $190.92 million. Lannett had a return on equity of 18.85% and a net margin of 7.44%. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the business posted $0.92 earnings per share. View Lannett's Earnings History.

When is Lannett's next earnings date?

Lannett is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for Lannett.

What price target have analysts set for LCI?

6 Wall Street analysts have issued 1 year target prices for Lannett's shares. Their predictions range from $18.00 to $25.00. On average, they expect Lannett's stock price to reach $20.80 in the next twelve months. View Analyst Ratings for Lannett.

Who are some of Lannett's key competitors?

Who are Lannett's key executives?

Lannett's management team includes the folowing people:
  • Mr. Martin P. Galvan CPA, VP of Fin., CFO & Treasurer (Age 66)
  • Mr. Robert Ehlinger, VP of Logistics & Chief Information Officer (Age 61)
  • Mr. Kevin R. Smith, Sr. VP of Sales & Marketing (Age 58)
  • Mr. John M. Abt, VP of Quality (Age 53)
  • Mr. Arthur P. Bedrosian, Director (Age 72)

Has Lannett been receiving favorable news coverage?

Media stories about LCI stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Lannett earned a news sentiment score of 0.13 on Accern's scale. They also assigned news articles about the company an impact score of 49.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $15.85.

How big of a company is Lannett?

Lannett has a market capitalization of $628.20 million and generates $633.34 million in revenue each year. The company earns $-580,000.00 in net income (profit) each year or $2.86 on an earnings per share basis. Lannett employs 1,126 workers across the globe.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.


MarketBeat Community Rating for Lannett (LCI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  342 (Vote Outperform)
Underperform Votes:  267 (Vote Underperform)
Total Votes:  609
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lannett (NYSE:LCI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Lannett in the last 12 months. Their average twelve-month price target is $20.80, suggesting that the stock has a possible upside of 31.23%. The high price target for LCI is $25.00 and the low price target for LCI is $18.00. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.40
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.80$20.80$21.40$21.00
Price Target Upside: 31.23% upside26.06% upside7.76% downside32.91% upside

Lannett (NYSE:LCI) Consensus Price Target History

Price Target History for Lannett (NYSE:LCI)

Lannett (NYSE:LCI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/22/2018OppenheimerReiterated RatingHoldHighView Rating Details
2/8/2018BMO Capital MarketsLower Price TargetMarket Perform -> Market Perform$22.00 -> $21.00LowView Rating Details
2/7/2018Roth CapitalSet Price TargetBuy$25.00LowView Rating Details
1/24/2018Goldman SachsInitiated CoverageNeutral -> Neutral$21.00MediumView Rating Details
8/14/2017Deutsche BankLower Price TargetHold$23.00 -> $19.00MediumView Rating Details
5/3/2017Robert W. BairdReiterated RatingOutperform$18.00MediumView Rating Details
8/24/2016Raymond JamesBoost Price TargetOutperform$31.00 -> $43.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Lannett (NYSE:LCI) Earnings History and Estimates Chart

Earnings by Quarter for Lannett (NYSE:LCI)

Lannett (NYSE:LCI) Earnings Estimates

2018 EPS Consensus Estimate: $2.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.52$0.68$0.60
Q2 20182$0.76$0.82$0.79
Q3 20182$0.72$0.76$0.74
Q4 20182$0.69$0.73$0.71

Lannett (NYSE LCI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018N/AView Earnings Details
2/7/2018Q2 2018$0.86$1.06$190.92 million$184.31 millionViewListenView Earnings Details
11/6/2017Q1 2018$0.52$0.60$153.62 million$155.00 millionViewN/AView Earnings Details
8/23/2017Q4 2017$0.40$0.40$139.01 million$139.10 millionViewN/AView Earnings Details
5/2/2017Q3 2017$0.87$0.77$170.28 million$165.72 millionViewListenView Earnings Details
2/1/2017Q217$0.84$0.92$169.04 million$171.00 millionViewListenView Earnings Details
11/3/2016Q117$0.71$0.77$166.72 million$161.60 millionViewN/AView Earnings Details
8/23/2016Q416$0.59$0.73$161.55 million$168.90 millionViewListenView Earnings Details
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details
8/25/2015Q415$0.86$0.91$97.21 million$99.28 millionViewListenView Earnings Details
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details
8/27/2014Q414$0.63$0.64$79.50 million$80.60 millionViewN/AView Earnings Details
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details
9/6/2012Q4 2012$0.03$0.06ViewN/AView Earnings Details
5/8/2012Q3 2012$0.04$0.05ViewN/AView Earnings Details
2/7/2012Q2 2012$0.03$0.02ViewN/AView Earnings Details
11/3/2011Q1 2012$0.01$0.03ViewN/AView Earnings Details
9/7/2011Q4 2011$0.02($0.07)ViewN/AView Earnings Details
5/11/2011Q3 2011$0.04($0.01)ViewN/AView Earnings Details
2/10/2011Q2 2011$0.01$0.09ViewN/AView Earnings Details
11/11/2010Q1 2011$0.04($0.02)ViewN/AView Earnings Details
9/13/2010Q4 2010$0.07$0.11ViewN/AView Earnings Details
5/12/2010Q3 2010$0.09$0.08ViewN/AView Earnings Details
11/9/2009Q1 2010$0.11ViewN/AView Earnings Details
9/9/2009Q4 2009$0.10ViewN/AView Earnings Details
5/12/2009Q3 2009$0.05ViewN/AView Earnings Details
2/11/2009Q2 2009$0.06ViewN/AView Earnings Details
11/13/2008Q1 2009$0.05ViewN/AView Earnings Details
9/29/2008Q4 2008($0.01)ViewN/AView Earnings Details
5/15/2008Q3 2008$0.01($0.05)ViewN/AView Earnings Details
2/8/2008Q2 2008($0.01)($0.03)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Lannett (NYSE:LCI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Lannett (NYSE LCI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.72%
Institutional Ownership Percentage: 98.40%
Insider Trading History for Lannett (NYSE:LCI)
Institutional Ownership by Quarter for Lannett (NYSE:LCI)

Lannett (NYSE LCI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2018David FarberMajor ShareholderSell10,000$25.01$250,100.004,171,269View SEC Filing  
12/13/2017David FarberMajor ShareholderSell184$30.00$5,520.004,181,269View SEC Filing  
12/5/2017David FarberMajor ShareholderSell9,816$30.05$294,970.804,190,169View SEC Filing  
12/1/2017David FarberMajor ShareholderSell10,000$26.88$268,800.004,191,269View SEC Filing  
11/27/2017Arthur P BedrosianCEOSell578$27.45$15,866.10636,616View SEC Filing  
11/24/2017Arthur P BedrosianCEOSell50,000$26.75$1,337,500.00636,616View SEC Filing  
11/22/2017Arthur P BedrosianCEOSell42,000$25.50$1,071,000.00636,616View SEC Filing  
11/8/2017Arthur P BedrosianCEOSell7,422$25.20$187,034.40679,001View SEC Filing  
11/8/2017David FarberMajor ShareholderSell10,000$25.03$250,300.004,211,069View SEC Filing  
2/6/2017Arthur P BedrosianCEOBuy10,000$20.00$200,000.00688,909View SEC Filing  
12/2/2016David FarberMajor ShareholderSell3,800$25.00$95,000.001,937,070View SEC Filing  
9/15/2016G. Michael LandisInsiderSell4,334$32.30$139,988.206,461View SEC Filing  
9/1/2016James M MaherDirectorSell1,478$33.91$50,118.9820,320View SEC Filing  
8/31/2016G. Michael LandisInsiderSell6,786$33.41$226,720.264,580View SEC Filing  
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.4640,104View SEC Filing  
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.6056,268View SEC Filing  
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27129,674View SEC Filing  
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00618,016View SEC Filing  
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.9820,500View SEC Filing  
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.0015,735View SEC Filing  
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.0038,397View SEC Filing  
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00604,376View SEC Filing  
9/8/2015John AbtVPBuy1,000$54.77$54,770.004,259View SEC Filing  
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00217,856View SEC Filing  
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.5399,821View SEC Filing  
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.1559,566View SEC Filing  
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.0059,566View SEC Filing  
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00632,152View SEC Filing  
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.0029,500View SEC Filing  
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Lannett (NYSE LCI) News Headlines

Source:
DateHeadline
Lannett (LCI) Scheduled to Post Quarterly Earnings on MondayLannett (LCI) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 4:28 AM
Lannett Co Inc (LCI) Expected to Post Earnings of $0.76 Per ShareLannett Co Inc (LCI) Expected to Post Earnings of $0.76 Per Share
www.americanbankingnews.com - April 23 at 3:18 AM
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations OfficerLannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
finance.yahoo.com - April 20 at 8:38 AM
Lannett (LCI) Upgraded at Zacks Investment ResearchLannett (LCI) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 19 at 5:50 PM
This Mornings Technical Outlook on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Lannett, and ...This Morning's Technical Outlook on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Lannett, and ...
www.prnewswire.com - April 18 at 8:29 AM
Lannett (LCI) Upgraded to "Buy" by Zacks Investment ResearchLannett (LCI) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - April 17 at 9:49 PM
Lannett (LCI) Lowered to Hold at BidaskClubLannett (LCI) Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 16 at 8:06 PM
Lannett (LCI) Stock Rating Lowered by BidaskClubLannett (LCI) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 12:49 AM
Why Lannett Company Inc (NYSE:LCI) May Not Be As Efficient As Its IndustryWhy Lannett Company Inc (NYSE:LCI) May Not Be As Efficient As Its Industry
finance.yahoo.com - April 13 at 8:37 AM
Lannett (LCI) Lowered to "Strong Sell" at BidaskClubLannett (LCI) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 12 at 6:14 PM
Edited Transcript of LCI presentation 6-Mar-17 7:50pm GMTEdited Transcript of LCI presentation 6-Mar-17 7:50pm GMT
finance.yahoo.com - April 12 at 8:57 AM
Lannett (LCI) Downgraded to "Sell" at Zacks Investment ResearchLannett (LCI) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 11 at 7:56 AM
Lannett (LCI) Stock Rating Lowered by Zacks Investment ResearchLannett (LCI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 10 at 9:45 AM
Lannett (LCI) Lifted to Buy at ValuEngineLannett (LCI) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 8 at 11:48 AM
Lannett Company, Inc. (LCI) Expected to Post Quarterly Sales of $176.30 MillionLannett Company, Inc. (LCI) Expected to Post Quarterly Sales of $176.30 Million
www.americanbankingnews.com - April 8 at 5:04 AM
Zacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Earnings of $0.76 Per ShareZacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Earnings of $0.76 Per Share
www.americanbankingnews.com - April 6 at 3:06 AM
Lannett (LCI) Raised to "Buy" at ValuEngineLannett (LCI) Raised to "Buy" at ValuEngine
www.americanbankingnews.com - April 1 at 12:08 AM
Lannett (LCI) Raised to "Buy" at Zacks Investment ResearchLannett (LCI) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 31 at 4:56 PM
Lannett Company, Inc. (LCI) Given Average Recommendation of "Hold" by AnalystsLannett Company, Inc. (LCI) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 31 at 3:36 PM
Lannett (LCI) Earns "Hold" Rating from OppenheimerLannett (LCI) Earns "Hold" Rating from Oppenheimer
www.americanbankingnews.com - March 23 at 6:06 PM
Lannett Strengthens, Augments Management TeamLannett Strengthens, Augments Management Team
finance.yahoo.com - March 23 at 8:32 AM
Zacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Quarterly Sales of $176.30 MillionZacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Quarterly Sales of $176.30 Million
www.americanbankingnews.com - March 22 at 8:08 AM
$0.76 EPS Expected for Lannett Company, Inc. (LCI) This Quarter$0.76 EPS Expected for Lannett Company, Inc. (LCI) This Quarter
www.americanbankingnews.com - March 20 at 5:16 AM
Valideas Top Five Healthcare Stocks Based On David Dreman - 3/18/2018 - NasdaqValidea's Top Five Healthcare Stocks Based On David Dreman - 3/18/2018 - Nasdaq
www.nasdaq.com - March 19 at 8:35 AM
Is Lannett Company (LCI) a Great Stock for Value Investors? - NasdaqIs Lannett Company (LCI) a Great Stock for Value Investors? - Nasdaq
www.nasdaq.com - March 17 at 8:41 AM
Is Lannett Company (LCI) a Great Stock for Value Investors?Is Lannett Company (LCI) a Great Stock for Value Investors?
finance.yahoo.com - March 16 at 6:17 PM
Lannett (LCI) Reports Separate Agreements with Three Strategic Alliance Partners - StreetInsider.comLannett (LCI) Reports Separate Agreements with Three Strategic Alliance Partners - StreetInsider.com
www.streetinsider.com - March 14 at 8:52 AM
Lannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance PartnersLannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance Partners
finance.yahoo.com - March 12 at 10:42 AM
Hat trick: Lannett enters into 3 product agreementsHat trick: Lannett enters into 3 product agreements
finance.yahoo.com - March 12 at 10:42 AM
Active-Investors: Free Post Earnings Research Report: Lannetts Quarterly Earnings Advanced 15.22%Active-Investors: Free Post Earnings Research Report: Lannett's Quarterly Earnings Advanced 15.22%
www.finanznachrichten.de - March 9 at 8:37 AM
Free Post Earnings Research Report: Lannetts Quarterly Earnings Advanced 15.22%Free Post Earnings Research Report: Lannett's Quarterly Earnings Advanced 15.22%
finance.yahoo.com - March 9 at 8:37 AM
Lannett Company, Inc. (LCI) Receives Average Rating of "Hold" from BrokeragesLannett Company, Inc. (LCI) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - March 6 at 5:26 PM
Snow Capital Management LP Decreases Stake in Lannett Company, Inc. (LCI)Snow Capital Management LP Decreases Stake in Lannett Company, Inc. (LCI)
www.americanbankingnews.com - March 5 at 12:55 PM
$176.30 Million in Sales Expected for Lannett Company, Inc. (LCI) This Quarter$176.30 Million in Sales Expected for Lannett Company, Inc. (LCI) This Quarter
www.americanbankingnews.com - March 5 at 12:10 PM
Schroder Investment Management Group Purchases Shares of 151,100 Lannett Company, Inc. (LCI)Schroder Investment Management Group Purchases Shares of 151,100 Lannett Company, Inc. (LCI)
www.americanbankingnews.com - March 4 at 10:31 AM
Lannett To Participate At Three Investor Conferences In March - PR Newswire (press release)Lannett To Participate At Three Investor Conferences In March - PR Newswire (press release)
www.prnewswire.com - February 28 at 8:30 AM
Lannett To Participate At Three Investor Conferences In MarchLannett To Participate At Three Investor Conferences In March
finance.yahoo.com - February 27 at 8:33 AM
KBC Group NV Sells 41,128 Shares of Lannett Company, Inc. (LCI)KBC Group NV Sells 41,128 Shares of Lannett Company, Inc. (LCI)
www.americanbankingnews.com - February 25 at 6:54 AM
Valideas Top Five Healthcare Stocks Based On John Neff - 2/18 ... - NasdaqValidea's Top Five Healthcare Stocks Based On John Neff - 2/18 ... - Nasdaq
www.nasdaq.com - February 20 at 8:26 AM
Lannett (LCI) Downgraded by Zacks Investment Research to HoldLannett (LCI) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - February 19 at 11:58 AM
Valideas Top Five Healthcare Stocks Based On Martin Zweig - 2/18/2018 - NasdaqValidea's Top Five Healthcare Stocks Based On Martin Zweig - 2/18/2018 - Nasdaq
www.nasdaq.com - February 19 at 8:26 AM
Q3 2018 Earnings Estimate for Lannett Company, Inc. (LCI) Issued By OppenheimerQ3 2018 Earnings Estimate for Lannett Company, Inc. (LCI) Issued By Oppenheimer
www.americanbankingnews.com - February 12 at 4:26 AM
Lannett (LCI) PT Lowered to $21.00Lannett (LCI) PT Lowered to $21.00
www.americanbankingnews.com - February 11 at 5:55 PM
Lannetts (LCI) CEO Tim Crew on Q2 2018 Results - Earnings Call TranscriptLannett's (LCI) CEO Tim Crew on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - February 11 at 4:05 PM
Lannett (LCI) Lifted to "Strong-Buy" at Zacks Investment ResearchLannett (LCI) Lifted to "Strong-Buy" at Zacks Investment Research
www.americanbankingnews.com - February 10 at 1:06 PM
FY2022 Earnings Estimate for Lannett Company, Inc. Issued By Oppenheimer (LCI)FY2022 Earnings Estimate for Lannett Company, Inc. Issued By Oppenheimer (LCI)
www.americanbankingnews.com - February 9 at 6:14 PM
Lannett Company, Inc. (LCI) Receives Average Recommendation of "Hold" from BrokeragesLannett Company, Inc. (LCI) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - February 9 at 5:50 PM
Why Lannett Company, Inc. Is Falling TodayWhy Lannett Company, Inc. Is Falling Today
finance.yahoo.com - February 9 at 9:47 AM
Lannetts (LCI) Hold Rating Reiterated at OppenheimerLannett's (LCI) Hold Rating Reiterated at Oppenheimer
www.americanbankingnews.com - February 8 at 7:48 PM
Lannett (LCI) PT Set at $25.00 by Roth CapitalLannett (LCI) PT Set at $25.00 by Roth Capital
www.americanbankingnews.com - February 8 at 3:18 PM

SEC Filings

Lannett (NYSE:LCI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Lannett (NYSE:LCI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Lannett (NYSE LCI) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.